Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus.
about
Antihypertensive agents for preventing diabetic kidney diseaseAntihypertensive agents for preventing diabetic kidney diseaseWhat is the impact of the ACE gene insertion/deletion (I/D) polymorphism on the clinical effectiveness and adverse events of ACE inhibitors?--Protocol of a systematic reviewDoes the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy?--A systematic review.Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes.Calcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT(1)-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertension.ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria.Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes.Diabetic renal disease: from recent studies to improved clinical practice.New concepts in blood pressure-lowering management in diabetic patients: the case for early ACE inhibitor combination therapy with diuretics.Effects of perindopril in hypertensive patients with or without type 2 diabetes mellitus, and with altered insulin sensitivity.Conservative Management of Chronic Renal Failure.Do agents that block the RAS truly offer renoprotective effects in early stage, nonproteinuric nephropathy?Effect of ACE-inhibition on coronary microvascular function and symptoms in normotensive women with microvascular angina: A randomized placebo-controlled trial.
P2860
Q24202090-F3EBFA46-4E73-459A-A3FC-61BFF83A4B34Q24245557-2B5ACDB8-2CEF-4416-9DD1-AEEF26888920Q24794522-B31A780D-38BC-4C0D-B36D-B31D445A52AAQ24816744-6859CC80-639A-4B15-ACDA-02873AA7A02FQ34704542-40B0EBB6-AA6A-4CC2-979F-8E91426EBD28Q34732964-3B8BA86D-913C-44CB-B35D-9C6E0DD25F61Q34849534-96D44F11-0A99-48F7-B51F-F364F5641DCDQ35106214-27106EAF-A79C-4346-B9C7-86EEEE0CABD9Q35161366-D66540CE-D25A-4AD3-B105-FB75754A23D2Q35620727-23454E68-9D32-4C10-83FC-44E4B18125DFQ36216253-3EA7E9B8-A065-4968-AB47-4A1AE30FE104Q36956471-2E094482-D016-4C0B-A685-7E7D54DD5445Q37039603-17971D97-95F6-4E01-9196-29470357C817Q37051470-86B0C547-047B-496F-969C-E70204883080Q55286779-A24A372C-4BE1-4070-93AA-E006F3B7E336
P2860
Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Randomized placebo-controlled ...... with type 1 diabetes mellitus.
@ast
Randomized placebo-controlled ...... with type 1 diabetes mellitus.
@en
type
label
Randomized placebo-controlled ...... with type 1 diabetes mellitus.
@ast
Randomized placebo-controlled ...... with type 1 diabetes mellitus.
@en
prefLabel
Randomized placebo-controlled ...... with type 1 diabetes mellitus.
@ast
Randomized placebo-controlled ...... with type 1 diabetes mellitus.
@en
P2093
P356
P1476
Randomized placebo-controlled ...... with type 1 diabetes mellitus.
@en
P2093
Gregersen G
Pedersen RS
P356
10.1093/QJMED/94.2.89
P407
P577
2001-02-01T00:00:00Z